BOTEC Analysis is a research and consulting firm specializing in drug policy, including the emerging marijuana markets. BOTEC has gained international recognition for providing useful research and analysis that empowers stakeholders to make informed decisions within the regulated cannabis industry. Our Chairman is Mark Kleiman, who co-authored Drugs and Drug Policy: What Everyone Needs to Know, and Marijuana Legalization: What Everyone Needs to Know, and founded BOTEC with the belief that sensible drug policy should do no harm, serve the public interest, and be grounded in fact. Unfortunately, uninformed drug policy has generated a spectacular range of unintended consequences. Today, BOTEC works with jurisdictions and organizations around the world to provide decision-makers with accurate and relevant information to support drug policy targeted to the interests of the public.
*Please note: BOTEC does not perform work or accept money from any entity that engages in the commercial cannabis business in the United States*
Estimates of legal cannabis market size and demand
Equivalency and potency calculations for marijuana flower concentrates and edibles
Industry trend analyses and whitepapers
Custom business analytics and insights
Legalization implementation advisory services, including governance and administrative structures, legislative agenda, regulatory process and priorities, budget priorities, communication planning, and data gathering and analysis